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Abstract  
The targeting and insertion of tail-anchored (TA) integral membrane proteins (IMP) into the 
correct membrane is critical for cellular homeostasis. The fungal protein Sgt2, and its human 
homolog SGTA, is the entry point for clients to the Guided Entry of Tail-anchored protein (GET) 
pathway, which targets ER-bound TA IMPs. Consisting of three structurally independent 
domains, the C-terminus of Sgt2 binds to the hydrophobic transmembrane domain (TMD) of 
clients. However, the exact binding interface within Sgt2 and molecular details that underlie its 
binding mechanism and client preference are not known. Here, we reveal the mechanism of Sgt2 
binding to hydrophobic clients, including TA IMPs. Through sequence analysis, biophysical 
characterization, and a series of capture assays, we establish that the Sgt2 C-terminal domain is 
flexible but conserved, and sufficient for client binding. A molecular model for this domain 
reveals a helical hand forming a hydrophobic groove approximately 15Å long, that is consistent 
with our observed higher affinity for client TMDs with a hydrophobic face and a minimal length 
of 11 residues. This work places Sgt2 into a broader family of TPR-containing co-chaperone 
proteins, demonstrating structural and sequence-based similarities to the DP domains in the yeast 
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Introduction 
An inherently complicated problem of cellular homeostasis is the biogenesis of hydrophobic 
IMPs which are synthesized in the cytoplasm and must be targeted and inserted into a lipid 
bilayer. Accounting for ~25% of transcribed genes (1), IMPs are primarily targeted by cellular 
signal binding factors that recognize a diverse set of hydrophobic -helical signals as they 
emerge from the ribosome (2-4). One important class of IMPs are tail-anchored (TA) proteins 
whose hydrophobic signals are their single helical transmembrane domain (TMD) located near 
the C-terminus and are primarily targeted post-translationally to either the ER or mitochondria 
(5-9). In the case of the canonical pathway for ER-destined TA IMPs, each is first recognized by 
homologs of mammalian SGTA (small glutamine tetratricopeptide repeat protein) (4, 6, 10, 11). 
Common to all signal binding factors is the need to recognize, bind, and then hand off a 
hydrophobic helix. How such factors can maintain specificity to a diverse set of hydrophobic 
clients that must subsequently be released remains an important question. 
Homologs of Saccharomyces cerevisiae Sgt2 (ySgt2) and Homo sapiens SGTA (referred to 
here as hSgt2 and collectively Sgt2 for simplicity), are involved in a variety of cellular processes 
regarding the homeostasis of membrane proteins including the targeting of TA IMPs (9, 12-14), 
retrograde transport of membrane proteins for ubiquitination and subsequent proteasomal 
degradation (15), and regulation of mislocalized membrane proteins (MLPs) (16, 17). Among 
these, the role of Sgt2 in the primary pathways responsible for targeting TA clients to the 
endoplasmic reticulum (ER) is best characterized, i.e. the fungal Guided Entry of Tail-anchored 
proteins (GET) or the mammalian Transmembrane Recognition Complex (TRC) pathway. In the 
GET pathway, Sgt2 functions by binding a cytosolic TA client then transferring the TA client to 
the ATPase chaperone Get3 (human homolog is also Get3) with the aid of the heteromeric 
Get4/Get5 complex (human Get4/Get5/Bag6 complex) (13, 18-20). In this process, TA client 
binding to Sgt2, after hand-off from Hsp70, is proposed as the first committed step to ensure that 
ER TA clients are delivered to the ER membrane while mitochondrial TA clients are excluded (3, 
13, 21). Subsequent transfer of the TA client from Sgt2 to the ATP bound Get3 induces 
conformational changes in Get3 that trigger ATP hydrolysis, releasing Get3 from Get4 and 
favoring binding of the Get3-TA client complex to the Get1/2 receptor at the ER leading to 
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get2Δ, or get3Δ) cause cytosolic aggregation of TA clients dependent on Sgt2 (26, 27). 
In addition to targeting TA IMPs, there is evidence hSgt2 promotes degradation of IMPs 
through the proteasome by cooperating with the Bag6 complex, a heterotrimer containing Bag6, 
hGet4, and hGet5, which acts as a central hub for a diverse physiological network related to 
protein targeting and quality control (19, 28-30). The Bag6 complex can associate with ER 
membrane-embedded ubiquitin regulatory protein UbxD8, transmembrane protein gp78, 
proteasomal component Rpn10c, and an E3 ubiquitin protein ligase RNF126 thereby connecting 
hSgt2 to ER associated degradation (ERAD) and proteasomal activity. Depletion of hSgt2 
significantly inhibits turnover of ERAD IMP clients and elicits the unfolded protein response 
(16). Furthermore, the cellular level of MLPs in the cytoplasm could be maintained by co-
expression with hSgt2, which possibly antagonize ubiquitination of MLPs to prevent 
proteasomal degradation (15, 17). These studies demonstrate an active role of hSgt2 in triaging 
IMPs in the cytoplasm and the breadth of hSgt2 clients including TA IMPs, ERAD, and MLPs all 
harboring one or more TMD. Roles for hSgt2 in disease include polyomavirus infection (31), 
neurodegenerative disease (27, 32), hormone-regulated carcinogenesis (33, 34), and myogenesis 
(35), although the underlying molecular mechanisms are still unclear. 
The architecture of Sgt2 includes three structurally independent domains that define the 
three different interactions of Sgt2 (Fig. 1A) (12, 36-39). The N-terminal domain forms a homo-
dimer composed of a four-helix bundle with 2-fold symmetry that primarily binds to the 
ubiquitin-like domain (UBL) of Get5/Ubl4A for TA IMP targeting (36, 40) or interacts with the 
UBL on the N-terminal region of Bag6 (41) where it is thought to initiate downstream 
degradation processes (15, 28, 29). The central region comprises a co-chaperone domain with 
three repeated TPR motifs arranged in a right handed-superhelix forming a ‘carboxylate clamp’ 
for binding the C-terminus of heat-shock proteins (HSP) (12, 42). The highly conserved TPR 
domain was demonstrated to be critical in modulating propagation of yeast prions by recruiting 
HSP70 (27) and may associate with the proteasomal factor Rpn13 to regulate MLPs (43). More 
recently, it was demonstrated that mutations to residues in the TPR domain which prevent Hsp70 
binding impair the loading of TA clients onto ySgt2  (21), consistent with a direct role of Hsp70 
in TA IMP targeting via the TPR domain. The C-terminal methionine-rich domain of Sgt2 is 
responsible for binding to hydrophobic clients such as TA IMPs [11,37,44]. Other hydrophobic 
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Vpu (viral protein U) from human immunodeficiency virus type-1 (HIV-1), the TMD of tetherin 
(44), the signal peptide of myostatin (35), and the N-domain of the yeast prion forming protein 
Sup35 (27). All of these studies suggest that the C-terminus of Sgt2 binds broadly to 
hydrophobic stretches, yet structural and mechanistic information for client recognition is 
lacking.  
In this study, we provide the first structural characterization of the C-domains from Sgt2 
(Sgt2-C) and show that, in the absence of substrate, it is relatively unstructured. We demonstrate 
that a conserved region of the C-domain, defined here as Ccons, is sufficient for client binding. 
Analysis of the Ccons sequence identifies six amphipathic helices whose hydrophobic residues are 
required for client binding. Based on this, we computationally generate an ab initio structural 
model that is validated by point mutants and disulfide crosslinking. Artificial clients are then 
used to define the properties within clients critical for binding to Sgt2-C. The results show that 
Sgt2-C falls into a larger STI1 family of TPR-containing co-chaperones and allow us to propose 
a mechanism for client binding. 
Results
The flexible Sgt2-C domain  
Based on sequence alignment (Fig. 1A), the Sgt2-C contains a conserved core of six 
predicted helices flanked by unstructured loops that vary in length and sequence. Previous 
experimental work suggested that this region is particularly flexible, as this domain in the 
Aspergillus fumigatus homolog is sensitive to proteolysis (12). Similarly, for ySgt2-TPR-C, the 
sites sensitive to limited proteolysis primarily occur within the loops flanking the conserved 
helices (Fig. 1A, red arrows and S1B). This flexible nature of the C-domain likely contributes to 
its anomalous passage through a gel-filtration column where Sgt2-C elutes much earlier than the 
similarly-sized, but well-folded, Sgt2 TPR-domain (Fig. 1B), as is typical for unstructured 
proteins [REF]. The larger hydrodynamic radius matches previous small-angle X-ray scattering 
measurement of the ySgt2 TPR-C domain that indicated a partial unfolded characteristic in a 
Kratky plot analysis. The circular dichroism (CD) spectra for both homologs suggests that the C-
domain and a predicted six -helical methionine-rich region of Sgt2-C (Fig. 1A), hereafter 
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assignable to a defined secondary structure category (Fig. 1C, S1A) (45). The well-resolved, 
sharp, but narrowly dispersed chemical shifts of the backbone amide protons in 1H-15N HSQC 
spectra of Sgt2-C (Fig. 1D,E) and Sgt2-Ccons (Fig. S1B,C), indicate a significant degree of 
backbone mobility, similar to natively unfolded proteins (46) and consistent with results seen by 
others (47), further highlighting the lack of stable tertiary structure (12). Taken all together, Sgt2-
C appears to be a flexible domain. 
The conserved region of the C-domain is sufficient for substrate binding 
We then asked if the flexible Sgt2-C is the site of client binding in the co-chaperone and if 
so, where within this domain is the binding region. During purification Sgt2-C is susceptible to 
proteolytic activity being cut at several specific sites (Fig. 1A). Proteolysis occurred primarily at 
Leu327 and in the poorly conserved N-terminal region (between Asp235-Gly258). Given the 
intervening region (ySgt2 G258-L327) is conserved (Fig 1A), it and the corresponding region in 
hSgt2 may mediate client binding (Fig. 2A, grey). To test this, we established a set of his-tagged 
Sgt2 constructs of various lengths (Fig. 2C, Fig. S2A). These Sgt2-C truncations were co-
expressed with an MBP-tagged client, Sbh1, and binding was detected by the presence of 
captured TA clients in nickel elution fractions (Fig. 2B). The TA protein Sbh1 is the yeast 
homolog of the mammalian Sec61-gamma, a component of the ER-resident Sec translocon. 
While the relative efficiency of MBP-Sbh1 capture cannot be assessed in this assay due to 
differences in total protein levels (Fig. S2B), we can demonstrate the ability of a given construct 
to bind to the client. As previously seen (13), we confirm that Sgt2-TPR-C alone is sufficient for 
capturing a client (Fig. 2C). As one might expect, the C-domain was also sufficient for binding 
the client. Interestingly, Sgt2-Ccons is sufficient for binding to Sbh1. Even a minimal region of the 
last 5 helices (referred to as H0) also captures Sbh1 (Fig. 2C). The predicted helices in Sgt2-
Ccons are amphipathic and their hydrophobic faces may be used for client binding (Fig. 2D).  
Each of the six helices in Sgt2-Ccons was mutated to replace the larger hydrophobic residues 
with alanines, dramatically reducing the overall hydrophobicity. For all of the helices, alanine 
replacement of the hydrophobic residues significantly reduces binding of Sbh1 to Sgt2-C (Fig. 
2E & F). While these mutants expressed at similar levels to the wild-type sequence, one cannot 
rule out that some of these changes may affect the tertiary structure of this domain. In general, 
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of the hydrophobic faces disrupts binding. The overall effect on binding by each helix is 
different, with mutations in helices 1-3 having the most dramatic reduction in binding suggesting 
that these are more crucial for Sgt2-client complex formation. It is also worth noting, as this is a 
general trend, that hSgt2 is more resistant to mutations that affect binding (Fig. 2F) than ySgt2, 
which likely reflect different thresholds for binding. 
Molecular modeling of Sgt2-C domain 
Despite the need for a molecular model, the C-domain has resisted structural studies, likely 
due to the demonstrated inherent flexibility. Based on the six conserved -helical amphipathic 
segments (Fig. 1A) that contain hydrophobic residues critical for client binding (Fig. 2D-E), we 
expect some folded structure to exist. Therefore, we performed ab initio molecular modeling of 
Sgt2-C using a variety of prediction methods resulting in a diversity of putative structures [48-
52]. As expected, all models showed buried hydrophobic residues as this is a major criterion for 
in silico protein folding. Residues outside the ySgt2-Ccons region adopted varied conformations 
consistent with their expected higher flexibility. Pruning these N- and C-terminal regions to 
focus on the ySgt2-Ccons region (Fig. S3A) revealed a potential binding interface for a 
hydrophobic substrate. Examples are seen in Quark models (1, 4, & 6 shown), Robetta 1 & 2, 
and I-TASSER 2 & 3, whereas others models had no clearly distinguishable groove. Given the 
intrinsic flexibility of the Sgt2-C domain, it is possible that models without a groove are found in 
the non-TMD bound structural ensemble. 
For a working model of TMD-bound ySgt2-C, we chose the highest scoring Quark 
structures where a general consistent architecture is seen (Fig. 3A) (48). The overall model 
contained a potential client binding site, a hydrophobic groove formed by the amphipathic 
helices. The groove is approximately 15 Å long, 12 Å wide, and 10 Å deep, which is sufficient to 
accommodate three helical turns of an -helix, ~11 amino acids (Fig. 3B). 
To validate the model, we interrogated the accuracy of the predicted structural arrangement 
by determining distance constraints from crosslinking experiments. We selected four pairs of 
residues in close spatial proximity and one pair far apart based on the Quark models (Fig. 4A). 
Calculating a C -C  distance between residue pairs for each model (Fig. 4F), the Quark models 1 
and 3 were the most consistent with an expected distance of 9Å or less for the close pairs. In all 
alternative models, the overall distances are much larger and should not be expected to form 
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disulfide bonds in vitro if they represent a TMD-bound state. For Robetta, a number of the 
models have pairs of residues within 9Å and Robetta’s per-residue error estimate suggests 
relatively high confidence in the Ccons region (Fig. S3B).  
As a control, we first confirmed that the cysteine-mutant pairs do not affect the function of 
ySgt2. We utilized an in vitro capture assay where a yeast Hsp70 homolog Ssa1 loaded with a TA 
client, Bos1, delivers the client to ySgt2 (21, 49, 50) (Fig. 4C). Purified Ssa1 is mixed with 
detergent solubilized strep-tagged Bos1-TMD (a model ER TA client) that contained a p-
benzoyl-l-phenylalanine (BPA) labeled residue, Bos1BPA, and diluted to below the critical micelle 
concentration resulting in soluble complexes of Bos1BPA/Ssa1. Full-length ySgt2 variants were 
each tested for the ability to capture Bos1BPA from Ssa1. After the transfer reaction, each was 
UV-treated to generate Bos1 crosslinks. Successful capture of the TA clients by ySgt2 was 
detected for all cysteine variants using an anti-strep Western blot and the appearance of a 
Bos1BPA/ySgt2 crosslink band, suggesting the mutations do not affect the structure or function of 
ySgt2 (Fig. 4C).  
We and others have demonstrated that a monomeric Sgt2 is sufficient for binding to clients 
(13). For the distance experiment, each of the cysteine-mutant pairs was made in the more stable 
monomeric variant ySgt2-TPR-C. Each variant was coexpressed with an artificial client - a 
cMyc-tagged BRIL (small, 4-helix bundle protein used in previous work to aid in the 
crystallization of GPCRs (51)) with a C-terminal TMD consisting of eight leucines and three 
alanines, denoted 11[L8], and purified via nickel-affinity chromatography in reducing buffer 
(Fig. S4A). All of the ySgt2 mutants bound to the client and behaved similar to the wild-type 
(cysteine-free) further suggesting the mutants did not perturb the native structure (Fig. S4B). For 
disulfide crosslink formation, each eluate was oxidized, digested using the protease Glu-C, and 
crosslinks were identified by the visualization of a reducing-agent sensitive ~7.7kDa fragment in 
gel electrophoresis (Fig. 4D). For both the wild-type construct and in N285C/G329C, where the 
pairs are predicted from the Quark models to be too distant for disulfide bond formation, no 
higher molecular weight band was observed. For the remaining pairs that are predicted to be 
close enough for bond formation, the 7.7kDa fragment was observed in each case and is labile in 
reducing conditions. Again, these results support the Ccons model derived from Quark. 
With the four crosslinked pairs as distance constraints, new models were generated using 
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Robetta models from these runs are similar to the top scoring models from Quark (Fig. 3). 
Satisfyingly, the pair of residues that do not form disulfide crosslinks are generally consistent 
(Fig. S5B). 
The improvement of the ySgt2 models predicted by Robetta with restraints included 
encouraged us to generate models for hSgt2-C with constraints. For this, pairs were defined 
based on sequence alignments of Sgt2 (Fig. 1A) and used as restraints. The resulting predictions 
had architectures consistent with the equivalent regions predicted for ySgt2-Ccons, for example 
Robetta 4 (Fig. S5C, top). Although in general the predicted hSgt2 model is similar to that for 
ySgt2, the region that corresponds to H2 occupies a position that precludes a clear hydrophobic 
groove. For ySgt2, the longer N-terminal loop occupies the groove preventing the exposure of 
hydrophobics to solvent (Fig. 3C, grey). For hSgt2, the shorter N-terminal loop may not be 
sufficient to similarly occupy the groove and allowing for the clear hydrophobic hand seen for 
the ySgt2-C. To correct for this, we replaced the sequence of the N-terminal loop of hSgt2-C 
with the ySgt2-C loop and ran structure prediction with the pairwise distance restraints. This 
resulted in a model where the loop occupies the groove and, when pruned away suggests the 
hydrophobic hand seen in yeast (Fig. S5C, middle boxed). Of note, we also generated models of 
hSgt2-C using the most recent Robetta method (transform-restrained) which produces new 
structures with a groove and similar helical-hand architecture across the board (Fig. S5C, 
bottom). 
We sought to further test the robustness of our model considering the intrinsic flexibility of 
Sgt2-C by probing for disulfide bond formation with neighboring residues of one of our 
crosslinking pairs. While the C -C  distance puts these adjacent pairs at farther than 9Å, mutating 
residues to cystines and measuring S-S distances across all possible pairs of rotamers provides a 
wider interval on possible distances and, therefore, the likelihood a disulfide bond will form (Fig. 
4E). Cysteine mutants were introduced to the residues adjacent to M289 and A319 in ySgt2-
TPR-C resulting in four additional pairs: K288C/A319C, M290C/A319C, M289C/P318C, and 
M289C/L320C. As described previously, these mutants were coexpressed with a substrate, in this 
case the cMyc-tag was replaced with an MBP-tag. The MBP-tag on the artificial client allows for 
tandem amylose- and nickel-affinity chromatography to ensure eluates contained only Sgt2-TPR-
C bound to substrate. Disulfide bond formation was conducted as before and a reductant 
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of these C-C pairs might suggest against disulfide bond formation, given the intrinsic flexibility 
of Sgt2-C, it is not surprising that each of these pairs are able to form disulfide bonds. As before, 
disulfide bond formation was detected for the M289C/A319C pair. In this new construct, we now 
see a small amount of disulfide bond formation in the distant N285C/G329C pair, likely an effect 
of switching to the MBP tag.  
Structural similarity of Sgt2-C domain to STI1 domains 
Attempts to glean functional insight for Sgt2-C from BLAST searches did not reliably return 
other families or non-Sgt2 homologs making functional comparisons difficult. A more extensive 
profile-based search using hidden Markov models from the SMART database (52) identified a 
similarity to domains in the yeast co-chaperone Sti1 (HOP in mammals). First called DP1 and 
DP2, due to their prevalence of aspartates (D) and prolines (P), these domains have been shown 
to be required for client-binding by Sti1 (53, 54) and are termed ‘STI1’-domains in 
bioinformatics databases (52). In yeast Sti1 and its human homolog HOP (combined will be 
referred to here as Sti1), each of the two STI1 domains (DP1 and DP2) are preceded by 
Hsp70/90-binding TPR domains, similar to the domain architecture of Sgt2. Deletion of the 
second, C-terminal STI1-domain (DP2) from Sti1 in vivo is detrimental, impairing native activity 
of the glucocorticoid receptor (53). In vitro, removal of the DP2 domain from Sti1 results in the 
loss of recruitment of the progesterone receptor to Hsp90 without interfering in Sti1-Hsp90 
binding (55). These results implicate DP2 in binding of Sti1 clients. In addition, others have 
noted that, broadly, STI1-domains may present a hydrophobic groove for binding the 
hydrophobic segments of a client (53, 54). Furthermore, the similar domain organizations (i.e.
Sgt2 TPR-C, Sti1 TPR-STI1) and molecular roles could imply an evolutionary relationship 
between these co-chaperones. Indeed, a multiple sequence alignment of the Sgt2-Ccons with 
several yeast STI1 domains (Fig. 5A) reveals strong conservation of structural features. H1-H5 of 
the predicted helical regions in Ccons align directly with the structurally determined helices in the 
alignment of hydrophobic residues in the amphipathic helices (53). 
Based on the domain architecture and homology, a direct comparison between the STI1 
domain and Sgt2-Ccons can be made. A structure of DP2 solved by solution NMR reveals that the 
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(53). The lengths of the -helices in this structure concur with those inferred from the alignment 
in Fig. 4A. Our molecular model of Sgt2-Ccons is strikingly similar to this DP2 structure (Fig. 
5B,C). An overlay of the DP2 structure and our molecular model demonstrates both Sgt2-Ccons 
and DP2 have similar lengths and arrangements of their amphipathic helices (Fig. 5D). 
Consistent with our observations of flexibility in Sgt2-Ccons, Sti1-DP2 generates few long-range 
NOEs between its helices indicating that Sti1-DP2 also has a flexible architecture (53). We 
consider this flexibility a feature of these helical-hands for reversible and specific binding of a 
variety of clients. 
Binding mode of clients to Sgt2
We examined the Sgt2-Ccons surface that putatively interacts with clients by constructing 
hydrophobic-to-charge residue mutations that are expected to disrupt capture of clients by Sgt2. 
Similar to the helix mutations in Fig. 2E&F, the capture assay was employed to establish the 
relative effects of individual mutations. A baseline was established based on the amount of the 
TA client Sbh1 captured by wild-type Sgt2-TPR-C. In each experiment, Sbh1 was expressed at 
refore, differences in binding should directly reflect the affinity of Sgt2 
mutants for clients. In all cases, groove mutations from hydrophobic to aspartate led to a 
reduction in client binding (Fig. 6). The effects are most dramatic with ySgt2 where each mutant 
significantly reduced binding by 60% or more (Fig. 6A). While all hSgt2 individual mutants saw 
a significant loss in binding, the results were more subtle with the strongest a ~36% reduction 
(M233D, Fig. 6B). Double mutants were stronger with a significant decrease in binding relative 
to the individual mutants, more reflective of the individual mutants in ySgt2. As seen before (Fig. 
2E&F), we observe that mutations toward the N-terminus of Sgt2-C have a stronger effect on 
binding than those later in the sequence, whether single point mutants in the case of ySgt2 or 
double mutants for hSgt2. 
Sgt2-C domain binds clients with a hydrophobic segment  11 residues
With a molecular model for ySgt2-Ccons and multiple lines of evidence for a hydrophobic 
groove, we sought to better understand the specific requirements for TMD binding. TMD clients 
were designed where the overall (sum) and average (mean) hydrophobicity, length, and the 
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Leu/Ala helical stretch followed by a Trp, were constructed as C-terminal fusions to the soluble 
protein BRIL (Fig. 7A). The total and mean hydrophobicity are controlled by varying the helix-
length and the Leu/Ala ratio. For clarity, we define a syntax for the various artificial TMD clients 
to highlight the various properties under consideration: hydrophobicity, length, and distribution. 
The generic notation is TMD-length[number of leucines] which is represented, for example, as 
18[L6] for a TMD of 18 amino acids containing six leucines. 
Our first goal with the artificial clients was to define the minimal length of a TMD to bind 
to the C-domain. As described earlier in our single point mutation capture assays, captures of his-
tagged Sgt2-TPR-C with the various TMD clients were performed. We define a relative binding 
efficiency as the ratio of captured TMD client by a Sgt2-TPR-C normalized to the ratio of a 
captured wild-type TA client by Sgt2-TPR-C. In this case we replaced the TMD in our artificial 
clients with the native TMD of Bos1 (Bos1TMD). The artificial client 18[L13] shows a 
comparable binding efficiency to Sgt2-TPR-C as that of Bos1TMD (Fig. 7B). From the helical 
wheel diagram of the TMD for Bos1, we noted that the hydrophobic residues favored one face of 
the helix. We explored this ‘hydrophobic face’ by using model clients that maintained this 
orientation while shortening the length and maintaining the average hydrophobicity of 18[L13] 
(Fig. 7B). Shorter helices of 14 or 11 residues, 14[L10] and 11[L8], also bound with similar 
affinity to Bos1. Helices shorter than 11 residues, 9[L6] and 7[L5], were not able to bind Sgt2-
TPR-C (Fig. 7B), establishing a minimal length of 11 residues for the helix, consistent with the 
dimensions of the groove predicted from the structural model (Fig. 3).  
Since a detected binding event occurs with TMDs of at least 11 amino acids, we decided to 
probe this limitation further. The dependency of client hydrophobicity was tested by measuring 
complex formation of Sgt2-TPR-C and artificial TMD clients containing an 11 amino acid TMD 
with increasing number of leucines (11[Lx]). As shown in Fig. 7C, increasing the number of 
leucines monotonically enhances complex formation, echoing previous results (56). hSgt2-TPR-
C binds to a wider spectrum of hydrophobic clients than ySgt2-TPR-C, which could mean it has 
a more permissive hydrophobic binding groove, also reflected in the milder impact of Ala 
replacement and Asp mutations in hSgt2-TPR-C to TMD client binding (Fig. 2F and Fig. 6B).  
Sgt2-C preferentially binds to TMDs with a hydrophobic face 
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the case of ySgt2, it has been suggested that the co-chaperone binds to TMDs based on 
hydrophobicity and helical propensity (56). In our system, our artificial TMDs consist of only 
alanines and leucines which have high helical propensities (57), and despite keeping the helical 
propensity constant and in a range that favors Sgt2 binding, there is still variation in binding 
efficiency. For the most part, varying the hydrophobicity of an artificial TMD client acts as 
expected, the more hydrophobic TMDs bind more efficiently to Sgt2-TPR-C (Fig. 7C). Our Ccons 
model suggests the hydrophobic groove of ySgt2-C protects a TMD with highly hydrophobic 
residues clustered to one side (see Fig. 3B). To test this, various TMD pairs with the same 
hydrophobicity, but different distributions of hydrophobic residues demonstrates TMD clients 
with clustered leucines have a higher relative binding efficiency than those with a more uniform 
distribution (Fig. 7D). Helical wheel diagrams demonstrate the distribution of hydrophobic 
residues along the helix (e.g. bottom Fig. 7D). The clustered leucines in the TMDs create a 
hydrophobic face which potentially interacts with the hydrophobic groove formed by the Sgt2-
Ccons region, corresponding to the model in Fig. 3B.  
Discussion 
Sgt2, the most upstream component of the GET pathway, plays a critical role in the 
targeting of TA IMPs to their correct membranes along with other roles in maintaining cellular 
homeostasis. Its importance as the first confirmed selection step of ER versus mitochondrial (56) 
destined TA IMPs necessitates a molecular model for client binding. Previous work demonstrated 
a role for the C-domain of Sgt2 to bind to hydrophobic clients, yet the exact binding domain 
remained to be determined. Through the combined use of biochemistry, bioinformatics, and 
computational modeling, we conclusively identify the minimal client-binding domain of Sgt2 
and preferences in client binding. Here we present a validated structural model of the Sgt2 C-
domain as a methionine-rich helical hand for grasping a hydrophobic helix and to provide a 
mechanistic explanation for binding a TMD of at least 11 hydrophobic residues. 
Identifying the C-domain of Sgt2 as containing a STI1 places Sgt2 into a larger context of 
conserved co-chaperones (Fig. 8A). In the co-chaperone family, the STI1 domains predominantly 
follow HSP-binding TPR domains connected by a flexible linker, reminiscent of the domain 
architecture of Sgt2. As noted above, for Sti1 these domains are critical for coordinated hand-off 
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two heat shock proteins. Both Sgt2 and the co-chaperone Hip coordinate pairs of TPR and STI1 
domains by forming stable dimers via their N-terminal dimerization domains (59). With evidence 
for a direct role of the carboxylate-clamp in the TPR domain of Sgt2 for TA client-binding now 
clear (21), one can speculate that the two TPR domains may facilitate TA client entry into 
various pathways that use multiple heat shock proteins.  
Computational modeling reveals that a conserved region, sufficient for client binding, forms 
a five alpha-helical hand which is reminiscent of other proteins involved in membrane protein 
targeting. Like Sgt2, the signal recognition particle (SRP) contains a methionine-rich domain that 
binds signal sequences and TMDs. While the helical order is inverted, again five amphipathic 
helices form a hydrophobic groove that cradles the client signal peptide (60) (Fig. 8B). Here once 
more, the domain has been observed to be flexible in the absence of client (61, 62) and, in the 
resting state, occupied by a region that includes a helix which must be displaced (60). Another 
helical-hand example recently shown to be involved in TA IMP targeting is calmodulin where a 
crystal structure reveals two helical hands coordinating to clasp a TMD at either end (Fig. 8B) 
(63). Considering an average TMD of 18-20 amino acids (to span a ~40Å bilayer), each half of 
calmodulin interacts with about 10 amino acids. This is in close correspondence to the 
demonstrated minimal 11 amino acids for a TMD client to bind to the monomeric Sgt2-TPR-C. 
In the context of the full-length Sgt2, one can speculate that the Sgt2 dimer may utilize both C-
domains to bind to a full TMD, similar to calmodulin. Cooperation of the two Sgt2 C-domains in 
client-binding could elicit conformational changes in the complex that could be recognized by 
downstream factors, such as additional interactions that increase the affinity to Get5/Ubl4A.  
Intriguingly, Sgt2-TPR-C preferentially binds to artificial clients with clustered leucines. 
The hydrophobic groove presented in the computational model provides an attractive explanation 
for this preference. In order to bind to the hydrophobic groove, a client buries a portion of its 
TMD in the groove leaving the other face exposed. Clustering the most hydrophobic residues 
contributes to the hydrophobic effect driving binding efficiency and protecting them from the 
aqueous environment. Indeed, when focusing on Sgt2’s role in TA IMP targeting, GET pathway 
substrates have been suggested to be more hydrophobic TMDs than EMC substrates (64). Of 
these, for the most hydrophobic substrates, like Bos1, residues on both sides of the TMD could 
be protected by a pair of C-domains. Alternatively, the unstructured N-terminal loop through H0 
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participating in substrate binding as well as capping a hydrophobic groove have both suggested 
in the context of other domains, e.g. with Get3 (4). The role for this clustering of hydrophobic 
residues in client recognition and targeting merits further investigation.  
What is the benefit of the flexible helical-hand structure for hydrophobic helix binding? 
While it remains an open question, it is notable that evolution has settled on similar simple 
solutions to the complex problem of specific but temporary binding of hydrophobic helices. For 
all of the domains mentioned above, the flexible helical-hands provide an extensive hydrophobic 
surface to capture a client-helix—driven by the hydrophobic effect. Typically, such extensive 
interfaces are between pairs of pre-ordered surfaces resulting in high affinities and slow off rates. 
These helical hands are required to only engage temporarily, therefore the flexibility offsets the 
favorable free energy of binding by charging an additional entropic cost for ordering a flexible 
structure in the client-bound complex. The benefit for clients is a favorable transfer to 
downstream components in the GET pathway as seen for ySgt2 (21) and hSgt2 (50). The 
demonstration that TA client transfer from hSgt2 to Get3 is twice as fast as disassociation from 
hSgt2 into solution, perhaps interaction with Get3 leads to conformational changes that further 
favor release (50). 
While hSgt2 and ySgt2 share many properties, there are a number of differences between 
the two homologs that may explain the different biochemical behavior. For the Ccons-domains, 
hSgt2 appears to be more ordered in the absence of client as the peaks in its NMR spectra are 
broader (Fig. S1B,C). Comparing the domains at the sequence level, while the high glutamine 
content in the C-domain is conserved it is higher in hSgt2 (8.8% versus 15.2%). The additional 
glutamines are concentrated in the predicted longer H4 helix (Fig. 1A). The linker to the TPR 
domain is shorter compared to ySgt2 while the loop between H3 and H4 is longer. Do these 
differences reflect different roles? As noted, in every case the threshold for hydrophobicity of 
client-binding is lower for hSgt2 than ySgt2 (Fig. 2E, 6, and 7) implying that the mammalian 
protein is more permissive in client binding. The two C-domains have similar hydrophobicity, so 
this difference in binding might be due to a lower entropic cost paid by having the hSgt2 C-
domain more ordered in the absence of client or the lack of an unstructured N-terminal loop.  
The targeting of TA clients presents an intriguing and enigmatic problem for understanding 
the biogenesis of IMPs. How subtle differences in each client modulates the interplay of hand-
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focus on a central player, Sgt2 and its client-binding domain. Through biochemistry and 
computational analysis, we provide a structural model that adds more clarity to client binding 
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Material and Methods 
Plasmid constructs 
MBP-Sbh1 full length, ySgt295-346 (ySgt2-TPR-C), ySgt2222-346 (ySgt2-C), ySgt2260-327 (ySgt2-
Ccons), ySgt2266-327 (ySgt2- H0), hSgt287-313 (hSgt2-TPR-C), hSgt2213-313 (hSgt2-C), hSgt2219-300
(hSgt2-Ccons), and hSgt2228-300 (hSgt2- H0) were prepared as previously described (12, 65). 
Genes of ySgt2 or hSgt2 variants were amplified from constructed plasmids and then ligated into 
an pET33b-derived vector with a 17 residue N-terminal hexa-histidine tag and a tobacco etch 
virus (TEV) protease site. Single or multiple mutations on Sgt2 were constructed by site-direct 
mutagenesis. Artificial clients were constructed in a pACYC-Duet plasmid with a N-terminal 
cMyc tag, BRIL fusion protein (66), GSS linker, and a hydrophobic C-terminal tail consisting of 
leucines and alanines and ending with a tryptophan. 
Protein expression and purification 
All proteins were expressed in Escherichia coli NiCo21 (DE3) cells (New England 
BioLabs). To co-express multiple proteins, constructed plasmids were co-transformed as 
described (65). Protein expression was induced by 0.3 mM IPTG at OD600 ~ 0.7 and harvested 
after 3 hours at 37°C. For structural analysis, cells were lysed through an M-110L Microfludizer 
Processor (Microfluidics) in lysis buffer (50 mM Tris, 300 mM NaCl, 25 mM imidazole 
supplemented with benzamidine, phenylmethylsulfonyl fluoride (PMSF), and 10 mM β-
mercaptoethanol (BME), pH 7.5). For capture assays, cells were lysed by freeze-thawing 3 times 
with 0.1 mg/mL lysozyme. To generate endogenous proteolytic products of ySgt2-TPR-C for MS 
analysis, PMSF and benzamidine were excluded from the lysis buffer. His-tagged Sgt2 and his-
tagged Sgt2/TA complexes were separated from the lysate by batch incubation with Ni-NTA 
resin at 4°C for 1hr. The resin was washed with 20 mM Tris, 150 mM NaCl, 25 mM imidazole, 
10 mM ΒME, pH 7.5. The complexes of interest were eluted in 20 mM Tris, 150 mM NaCl, 300 
mM imidazole, 10 mM ΒME, pH 7.5.  
For structural analysis, the affinity tag was removed from complexes collected after the 
nickel elution by an overnight TEV digestion against lysis buffer followed by size-exclusion 
chromatography using a HiLoad 16/60 Superdex 75 prep grade column (GE Healthcare). 
Measurement of Sgt2 protein concentration was carried out using the bicinchoninic acid 
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NMR and CD analyses were concentrated to 10-15 mg/mL for storage at −80°C before 
experiments.  
For the in vitro transfer assay, plasmids encoding for the full-length ySgt2 cysteine mutants 
were transformed into BL21 Star cells (Invitrogen). Cells were grown in 2x yeast-tryptone 
(2xYT) media and induced with 0.1mM IPTG at an OD600 of 0.6 then harvested after 3 hours at 
30°C by centrifugation. Cells were lysed in 50mM Tris pH 8.0, 500mM NaCl, 10% glycerol, and 
1x BugBuster (Millipore Sigma), supplemented with protease inhibitors (4-(2-
aminoethyl)benzenesulfonyl fluoride hydrochloride (Roche), benzamidine, and BME). Full-
length his-tagged ySgt2 and cysteine mutants were separated from the lysate by batch incubation 
with Ni-NTA resin (Qiagen) at 4°C for 1 hour. The resin was washed with 50mM Tris pH 8.0, 
500mM NaCl, 10% glycerol, and 25mM imidazole and then the protein was eluted in 50mM Tris 
pH 8.0, 500mM NaCl, 10% glycerol, and 300mM imidazole. For storage, protein was dialyzed in 
25mM K-HEPES pH 7.5, 150mM KOAc, and 20% glycerol at 4°C and then flash frozen in 
liquid nitrogen. Purified Bos1 with p-benzoyl-l-phenylalanine (BPA) labeled at residue 230 
(Bos1BPA) and yeast Ssa1 were gifts from the lab of Shu-ou Shan (Caltech). 
NMR Spectroscopy 
15N-labeled proteins were generated from cells grown in auto-induction minimal media as 
described (67) and purified in 20 mM phosphate buffer, pH 6.0 (for ySgt2-C, 10mM Tris, 
100mM NaCl, pH 7.5). The NMR measurements of 15N-labeled Sgt2-C proteins (~0.3-0.5 mM) 
were collected using a Varian INOVA 600 MHz spectrometer at either 25°C (ySgt2-C) or 35°C 
(hSgt2-C) with a triple resonance probe and processed with TopSpin™ 3.2 (Bruker Co.).  
CD Spectroscopy 
The CD spectra were recorded at 24°C with an Aviv 202 spectropolarimeter using a 1 mm 
path length cuvette with 10 μM protein in 20 mM phosphate buffer, pH 7.0. The CD spectrum of 
each sample was recorded as the average over three scans from 190/195 to 250 nm in 1 nm steps. 
Each spectrum was then decomposed into its most probable secondary structure elements using 
BeStSel (68). 
Glu-C digestion of the double cysteine mutants on ySgt2-C 
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the artificial client, 11[L8], with either a cMyc or MBP tag were purified as the other His-Sgt2 
complexes described above or initially purified via amylose affinity chromatography before 
nickel chromatography explained earlier. The protein complexes were mixed with 0.2 mM 
CuSO4 and 0.4 mM 1,10-phenanthroline at 24°C for 20 min followed by 50 mM N-ethyl 
maleimide for 15 min. Sequencing-grade Glu-C protease (Sigma) was mixed with the protein 
samples at an approximate ratio of 1:30 and the digestion was conducted at 37°C for 22 hours. 
Digested samples were mixed with either non-reducing or reducing SDS-sample buffer, resolved 
via SDS-PAGE using Mini-Protean® Tris-Tricine Precast Gels (10-20%, Bio-Rad), and 
visualized using Coomassie Blue staining.  
In vitro transfer assay of Bos1 from Ssa1 to ySgt2
The in vitro transfer assays were performed as in Chio et al. 2019 and Shao et al. 2017 (49, 
50). Specifically, 39µM Bos1BPA (50mM HEPES, 300mM NaCl, 0.05% LDAO, 20% glycerol) 
was diluted to a final concentration of 0.1µM and added to 4µM Ssa1 supplemented with 2mM 
ATP (25mM HEPES pH7.5, 150mM KOAc). After one minute, 0.3µM of full-length ySgt2 or 
mutant was added to the reaction. Samples were flash frozen after one minute and placed under a 
365nm UV lamp for 2 hours on dry ice to allow for BPA crosslinking. 
Protein immunoblotting and detection 
For western blots, protein samples were resolved via SDS-PAGE and then transferred onto 
nitrocellulose membranes by the Trans-Blot® Turbo™ Transfer System (Bio-Rad). Membranes 
were blocked in 5% non-fat dry milk and hybridized with antibodies in TBST buffer (50 mM 
Tris-HCl pH 7.4, 150 mM NaCl, 0.1% Tween 20) for 1 hour of each step at 24°C. The primary 
antibodies were used at the following dilutions: 1:1000 anti-penta-His mouse monoclonal 
(Qiagen), 1:5000 anti-cMyc mouse monoclonal (Sigma), and a 1:3000 anti-Strep II rabbit 
polyclonal (Abcam). A secondary antibody conjugated either to alkaline phosphatase (Rockland, 
1:8000) or a 800nm fluorophore was employed, and the blotting signals were chemically 
visualized with either the nitro-blue tetrazolium/5-bromo-4-chloro-3'-indolyphosphate 
(NBT/BCIP) chromogenic assay (Sigma) or infrared scanner. All blots were photographed and 
quantified by image densitometry using ImageJ (69) or ImageStudioLite (LI-COR Biosciences). 
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The densitometric analysis of MBP-Sbh1 capture by His-Sgt2-TPR-C quantified the 
intensity of the corresponding protein bands on a Coomassie Blue G-250 stained gel. The 
quantified signal ratios of MBP-Sbh1/His-Sgt2-TPR-C are normalized to the ratio obtained from 
the wild-type (WT). Expression level of MBP-Sbh1 was confirmed by immunoblotting the MBP 
signal in cell lysate. Average ratios and standard deviations were obtained from 3-4 independent 
experiments. 
In artificial client experiments, both his-tagged Sgt2-TPR-C and cMyc-tagged artificial 
clients were quantified via immunoblotting signals. The complex efficiency of Sgt2-TPR-C with 







where ETMD is the signal intensity of an eluted client representing the amount of client co-
purified with Sgt2-TPR-C and TTMD is the signal intensity of a client in total lysate which 
corresponds to the expression yield of that client. Identical volumes of elution and total lysate 
from different clients experiments were analyzed and quantified. In order to correct for possible 
variation the amount of Sgt2-TPR-C available for complex formation, Ecapture represents the 
relative amount of Sgt2-TPR-C present in the elution (ESgt2) compared to a pure Sgt2-TPR-C 
standard (Epurified,Sgt2). 
, (2) 
Each ETMD and TTMD value was obtained by blotting both simultaneously, i.e. adjacently on the 
same blotting paper. To facilitate comparison between clients, the Sgt2-TPR-C/TA client 
complex efficiency Ecomplex,TMD is normalized by Sgt2-TPR-C/Bos1 complex efficiency 
Ecomplex,Bos1. 
% Complex = Ecomplex,T
Ecomplex,B 1
 × 100 (3)
Sequence alignments 
An alignment of Sgt2-C domains was carried out as follows: all sequences with an 
annotated N-terminal Sgt2/A dimerization domain (PF16546 (70)), at least one TPR hit 
(PF00515.27, PF13176.5, PF07719.16, PF13176.5, PF13181.5), and at least 50 residues 
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as all residues following the TPR domain, filtered at 90% sequence identity using CD-HIT (71), 
and then aligned using MAFFT G-INS-i (72). Other attempts with a smaller set (therefore more 
divergent) of sequences results in an ambiguity in the relative register of H0, H1, H2, and H3 
when comparing Sgt2 with SGTA. 
Alignments of Sti1 (DP1/DP2) and STI1 domains were created by pulling all unique 
domain structures with annotated STI1 domains from Uniprot. Where present, the human 
homolog was selected and then aligned with PROMALS3D (73). PROMALS3D provides a way 
of integrating a variety of costs into the alignment procedure, including 3D structure, secondary 
structure predictions, and known homologous positions. 
All alignments were visualized using Jalview (74). 
Molecular modeling 
Putative models for ySgt2-C were generated with I-TASSER, PCONS, Quark, Robetta (ab 
initio and transform-restrained modes), Phyre2, and RaptorX via their respective web servers (48, 
75-78). The highest scoring model from Quark was then chosen to identify putative TA client 
binding sites by rigid-body docking of various transmembrane domains modelled as -helices 
(3D-HM (79)) into the ySgt2-Ccons through the Zdock web server (80). Pairwise distances were 
calculated between C  atoms (the closer C  proton on glycine) using mdtraj (81) . Based on our 
disulfide crosslinks, new models were predicted using Robetta in ab initio mode specifying C -
C  atom distance constraints bounded between 0 and 9 Å. 
For hSgt2, using the same set of structure prediction servers above, we were only able to 
produce a clear structural model using the Robetta transform-restrained mode. We were also 
unable to generate a reliable model by directly using the ySgt2-C model as a template (82). To 
crosslink distance data from ySgt2 as restraints for hSgt2, pair positions were transferred from 
one protein to the other via an alignment of Sgt2-C domains (excerpt in Fig. 1A) and ran Robetta 
ab initio. Also, we grafted the N-terminal loop of ySgt2-C on hSgt2-C with the same set of 
restraints. 
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Figures
Fig. 1. Structural characteristics of free Sgt2 C-domain. (A) Top, Schematic of the domain 
organization of Sgt2. Below, representative sequences from a large-scale multiple sequence 
alignment of the C domain: fungal Sgt2 from S. cerevisiae, S. pombe, and C. thermophilum and 
metazoan Sgt2 from C. savignyi, X. laevis, and H. sapiens. Protease susceptible sites on ySgt2-C 
identified by mass spectrometry are indicated by red arrowheads. Predicted helices of ySgt2 
(blue) and hSgt2 (orange) by Jpred (83) and/or structure prediction are shown. Blue/orange color 
scheme for ySgt2/hSgt2 is used throughout the text. Residues noted in the text are highlighted by 
an asterisk. (B) Overlay of size-exclusion chromatography traces of ySgt2-C (blue line), hSgt2-C 
(orange line), ySgt2-TPR (blue dash), and hSgt2-TPR (orange dash). Traces are measured at 214 
nm, baseline-corrected and normalized to the same peak height. (C) Far UV CD spectrum of 10 
μM of purified ySgt2-C (blue) and hSgt2-C (orange) at RT with secondary structure 
decomposition from BestSel (68). (D) 1H-15N HSQC spectrum of ySgt2-C at 25°C. The 
displayed chemical shift window encompasses all N-H resonances from both backbone and side 
chains. The range of backbone amide protons, excluding possible side-chain NH2 of Asn/Gln, is 
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Fig. 2. The minimal binding region of Sgt2 for client binding. (A) Diagram of the protein 
truncations tested for client binding that include the TPR-C domain, C-domain (C), Ccons, and 
Ccons H0 ( H0) from ySgt2 and hSgt2. The residues corresponding to each domain are 
indicated, and grey blocks highlight the Ccons region. (B) Schematic of capture experiments of 
MBP-tagged Sbh1 separated by a thrombin (Thr) cleavage site (MBP-Sbh1) by Sgt2 variants. 
After co-expression, cell pellets are lysed and NTA-Ni2+ is used to capture his-tagged Sgt2-TPR-
C. (C) Tris-Tricine-SDS-PAGE gel (84) of co-expressed and purified MBP-Sbh1 and his-tagged 
Sgt2 truncations visualized with Coomassie Blue staining. (D) Helical wheel diagrams of 
predicted helices (see Fig. 1A) in the Ccons domain of ySgt2 and hSgt2. Residues are colored by 
the Kyte and Doolittle hydrophobicity scale (85). (E) All of the hydrophobic residues (L, I, F, 
and M) in a predicted helix (H0, H1, etc.) are replaced with alanines and tested for the ability to 
capture MBP-Sbh1. Protein levels were quantified by Coomassie staining. Relative binding 
efficiency of MBP-Sbh1 by ySgt2 C-domain (ySgt2-C) variants was calculated relative to total 
amount of ySgt2-C captured (MBP-Sbh1/Sgt2-C) then normalized to the wild-type ySgt2-C. 
Experiments were performed 3-4 times and the standard deviations are presented. Total 
expression levels of the MBP-Sbh1 were similar across experiments as visualized by 
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Fig 3. A structural model for Sgt2-Ccons. (A) The top 10 models of the ySgt2-Ccons generated by 
the template-free algorithm Quark (48) are overlaid with the highest scoring model in solid. 
Models are color-ramped from N- (blue) to C-terminus (red). (B) A model of ySgt2-Ccons (surface 
colored by Kyte-Doolittle hydrophobicity) bound to a TMD (purple helix) generated by rigid-
body docking through Zdock (80). The darker purple corresponds to an 11 residue stretch. (C)
The entire ySgt2-C from the highest scoring model from Quark (Ccons in rainbow with the rest in 
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Fig 4. Validating the structural model with disulfide bond formation. Variants of His-ySgt2-
TPR-C (WT or cysteine double mutants) were co-expressed with the artificial client, cMyc-
BRIL-11[L8]. After lysis, ySgt2-TPR-C proteins were purified, oxidized, then digested by Glu-C 
protease and analyzed by gel either in non-reducing or reducing buffer. (A) C  ribbon of ySgt2-
Ccons color-ramped with various pairs of cysteines highlighted. Scissors indicate protease 
cleavage sites resulting in fragments less than 3 kDa in size. (B) A schematic of the transfer of 
Bos1BPA from Ssa1 to full-length ySgt2 to demonstrate the double cysteine mutants are still 
functional. (C) A western blot visualizing cross-linked ySgt2-Bos1 complexes. All samples 
tested, WT, N285C/G329C, A272C/L327C, I286C/M323C, M289C/A319C, and M289C/N322C, 
had a higher molecular weight appear after the addition of ySgt2 which corresponds to the size of 
the cross-linked complex. ((86) [86] . For the WT (cys-free) no significant difference was 
found between samples in non-reducing vs. reducing conditions. All close residue pairs 
(A272/L327, I286/M323, M289/A319, and M289/N322) show peptide fragments (higher MW) 
sensitive to the reducing agent and indicate disulfide bond formation (indicated by arrow). A 
cysteine pair (N285/G329) predicted to be far apart by the model does not result in the higher 
MW species. (E) Tris-Glycine SDS-PAGE gel probing the flexibility of ySgt2-Ccons. All new 
pairs (K288/A319, M290/A319, M289/P318, M289/L320) show peptide fragments sensitive to 
the reducing agent (indicated by arrow). The range of distances of the eight closest possible 
rotamer pairs is annotated below. The cysteine pair (N285/G329) shown to be far apart by the 
model does have a faint higher molecular weight band. (F) C -C  distances between the residues 
mutated to cysteines based on various models predicted by the Quark, I-TASSER, PCONS, and 
Robetta. Cysteine pairs that are 9Å or less colored in orange and are expected to be close enough 
to form disulfide bonds. Where all five pair distances are consistent with the experiment (4 near 
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Fig. 5. Comparison of Sti1 domains and the Sgt2-Ccons model. (A) Multiple sequence 
alignment of Sgt2-C with STI1 domains (DP1, DP2) from STI1/Hop homologs. Helices are 
shown based on the Sgt2-Ccons model and the ScSti1-DP1/2 structures. Species for representative 
sequences are from S. cerevisiae (Scer), S. pombe (Spom), C. thermophilum (Cthe), C. savignyi 
(Csav), and H. sapiens (Hsap). (B) C  ribbon of ScSgt2-Ccons color-ramped with large 
hydrophobic sidechains shown as grey sticks (sulfurs in yellow). (C) Similar to B for the solution 
NMR structure of Sti1-DP2526-582 (PDBID: 2LLW) (53). (D) Superposition of the Sgt2-Ccons
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Fig. 6. Effects on client binding of charge mutations to the putative hydrophobic groove of 
Sgt2-Ccons. For these experiments, individual point mutations are introduced into Sgt2-C and 
tested for their ability to capture Sbh1 quantified as in Figure 2D. (A) For ySgt2-C, a schematic 
and cartoon model are provided highlighting the helices and sites of individual point mutants 
both color-ramped for direct comparison. For the cartoon, the docked TMD is shown in purple. 
Binding of MBP-Sbh1 to his-tagged ySgt2-C and mutants were examined as in Figure 2E. Lanes 
for mutated residues are labeled in the same color as the schematic (B) Same analysis as in A for 
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Fig. 7. Minimal requirements for client recognition by Sgt2. (A) Schematic of model clients. 
From capture assays, quantification of complex formation in the eluate is calculated and 
normalized to that of complexes with Bos1TMD, here defined as relative binding efficiency. (B) 
Complex formation of ySgt2 (blue) and hSgt2 (orange) with the TA client Bos1TMD and several 
artificial clients noted x[Ly], where x denotes the length of the TMD and y denotes the number 
of leucines in the TMD. The helical wheel diagrams of the TMD of clients here and for 
subsequent panels with leucines colored in dark orange, alanines colored in pale orange, and 
tryptophans colored in grey. Each assay was performed four times except for ySgt2-Bos1 and 
hSgt2-9[L6], which were performed three times. (C) Complex formation of ySgt2-TPR-C and 
hSgt2-TPR-C with artificial clients with TMDs of length 11 and increasing numbers of leucine. 
Capture assays were repeated either two or three times. (D) Comparison of complex formation of 
ySgt2-TPR-C and hSgt2-TPR-C with artificial clients of the same lengths and hydrophobicities 
but differences in the distribution of leucines, i.e. clustered (solid line) vs distributed (dotted 
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Fig. 8. Various domain structures of STI1 and other helical-hand containing proteins. (A) 
The domain architectures of proteins with a STI1 domain were obtained initially from InterPro 
(87) and then adjusted as discussed in the text. Each domain within a protein is colored relative 
to the key. (B) Structural comparison of various hydrophobic-binding helical-hand protein 
complexes. For each figure only relevant domains are included. Upper row, color-ramped 
cartoon representation with bound helices in purple. Lower row, accessible surface of each 
protein colored by hydrophobicity again with docked helical clients in purple. In order, the 
predicted complex of ySgt2-Ccons and ScSbh2-TMD, DP1 domain from yeast Sti1 with N-
terminus containing H0 in grey (ScSti1-DP1)(PDBID: 2LLV), human calmodulin (HsCALM2) 
bound to a hydrophobic domain of calcineurin (HsPPP3CA) (PDBID: 2JZI), and M domain of 
SRP54 from Oryctolagus cuniculus (OcSRP54-M) and the signal sequence of human transferrin 
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1 10.1 9.1 7.0 7.4 6.2 44.0 28.3 30.7 24.2 31.01
2 6.5 9.1 11.6 15.0 12.4 23.7 11.1 17.1 18.9 21.12
3 15.7 6.0 6.2 6.8 9.2 45.1 39.6 31.6 24.6 33.33
4 6.7 10.1 14.1 19.4 16.0 16.8 15.7 8.2 12.8 12.94
5 15.6 13.5 4.9 8.3 10.1 22.9 9.8 8.6 11.5 13.25
6 11.3 8.5 14.6 22.9 19.4   12.8 10.4 10.66
7 16.2 7.2 5.8 8.7 9.8 23.0 22.0 20.5 29.3 29.37
8 7.6 11.6 10.3 14.4 10.7   13.8 10.7 10.78
9 8.8 18.6 10.7 12.5 10.8 43.3 26.1 25.6 20.3 26.5
10 6.9 14.2 11.1 14.2 10.7 17.2 12.2 7.4 16.9 13.0
1 17.6 7.8 8.4 13.9 15.7 8.6 7.1 9.8 13.3 11.01
2 21.3 9.6 11.5 17.9 17.9 14.1 13.3 9.1 20.8 14.12
3 24.6 12.4 14.8 17.8 21.3 18.1 5.6 6.3 13.2 13.13
4 20.2 11.1 12.1 19.9 21.0 8.8 9.8 9.9 10.0 7.64
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WT M277D I286D M290D I295D M315D L320D M323D L327D
1 0.14 0.13 0.18 0.21 0.34 0.23 0.29 0.40
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